| Literature DB >> 35129759 |
Ge Li1,2, Ping Zhu3,4,5,6,7,8, Qi-Song Su9,10, Dong-Lin Zhuang9,11, Moussa Ide Nasser9, Xiyalatu Sai12,13, Gang Deng9,14.
Abstract
Ischemic damage to the central nervous system (CNS) is a catastrophic postoperative complication of aortic occlusion subsequent to cardiovascular surgery that can cause brain impairment and sometimes even paraplegia. Over recent years, numerous studies have investigated techniques for protecting and revascularizing the nervous system during intraoperative ischemia; however, owing to a lack of knowledge of the physiological distinctions between the brain and spinal cord, as well as the limited availability of testing techniques and treatments for ischemia-reperfusion injury, the cause of brain and spinal cord ischemia-reperfusion injury remains poorly understood, and no adequate response steps are currently available in the clinic. Given the limited ability of the CNS to repair itself, it is of great clinical value to make full use of the proliferative and differentiation potential of stem cells to repair nerves in degenerated and necrotic regions by stem cell transplantation or mobilization, thereby introducing a novel concept for the treatment of severe CNS ischemia-reperfusion injury. This review summarizes the most recent advances in stem cell therapy for ischemia-reperfusion injury in the brain and spinal cord, aiming to advance basic research and the clinical use of stem cell therapy as a promising treatment for this condition.Entities:
Keywords: Cerebral ischemia–reperfusion injury; Functionally enhanced stem cells; Prototype stem cells; Spinal cord ischemia–reperfusion injury; Stem cell therapy
Year: 2022 PMID: 35129759 DOI: 10.1007/s10571-022-01204-9
Source DB: PubMed Journal: Cell Mol Neurobiol ISSN: 0272-4340 Impact factor: 5.046